Early Stage Drug Development Company
We’re development of Organ On-Chip System to which real human blood is applied
and drug application efficacy test and evaluation company
Neuroblastoma SH-SY5Y MTS comparative assay
Comparative study with cyclophosphamide, a generic drug for neuroblastoma
In the case of cyclophosphamide, which is a positive control, significance was confirmed at 100uM and 90uM. In the case of P9-cis RA and PARA, there was a significant difference at 70uM and 60uM, respectively, and it was confirmed that the effect was superior to that of cyclophosphamide.